Stakeholder Assessment of the Evidence for Cancer Genomic Tests: Insights from Three Case Studies

Insufficient evidence on the net benefits and harms of genomic tests in real-world settings is a translational barrier for genomic medicine. PURPOSE: Understanding stakeholders’ assessment of the current evidence base for clinical practice and coverage decisions should be a critical step to influenc...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Genet Med
Autori principali: Deverka, Patricia A., Schully, Sheri D., Ishibe, Naoko, Carlson, Josh J., Freedman, Andrew, Goddard, Katrina A.B., Khoury, Muin J., Ramsey, Scott D.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2012
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4437504/
https://ncbi.nlm.nih.gov/pubmed/22481130
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/gim.2012.3
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi